# Phosphodiesterase 5 inhibitor treatment and survival in interstitial lung disease pulmonary hypertension: a Bayesian retrospective observational cohort study
#
# Timothy JW Dawes [1], Colm McCabe [1,2], Konstantinos Dimopoulos [1,2,3], Iain Stewart [1], Simon Bax [2], 
# Carl Harries [2], Chinthaka Samaranayake [1], Aleksander Kempny [1,2,3], Philip L Molyneaux [1,4],
# Samuel Seitler [2], Thomas Semple [5], Wei Li [1,6], Peter George [1,4], Vasilis Kouranos [1,4],
# Felix Chua [1,4], Elisabetta A Renzoni [1,4], Maria Kokosi [1,4], Gisli Jenkins [1,4], Athol U Wells [1,4],
# S John Wort [1,2]*, Laura C Price [1,2,3]*
#
# [1] National Heart and Lung Institute, Imperial College London, UK
# [2] National Pulmonary Hypertension Service
# [3] Adult Congenital Heart Disease Service, Royal Brompton Hospital, London, UK
# [4] Department of Interstitial Lung Disease, Royal Brompton Hospital, London, UK
# [5] Department of Radiology, Royal Brompton Hospital, London
# [6] Department of Echocardiography, Royal Brompton Hospital, London, UK.
#
# *Joint senior authors
#
# Correspondence details: Laura C Price. laura.price@rbht.nhs.uk
#
